Tyzoon Nomanbhoy - Concepedia

Author

Tyzoon Nomanbhoy

Scripps Research Institute ORCID

Also Known As

Nomanbhoy, Tyzoon, T.K. Nomanbhoy, Tyzoon K Nomanbhoy, Tyzoon K. Nomanbhoy, Tyzoon Nomanbhoy, Tyzoon K. Nomanbhoy

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute Torrey Pines Institute For Molecular Studies Dana-Farber Cancer Institute Cornell University Harvard University

About

Tyzoon Nomanbhoy is an author at Scripps Research Institute specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	3.2K
2	Natural Sciences	16	19	2K
3	Biochemistry	14	16	1.5K
4	Engineering	2	2	162
5	Biology	1	1	41

Tyzoon Nomanbhoy

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation Baishan Jiang, Michael A. Erb, Yanke Liang, Nature Chemical Biology Selective Cdk9 InhibitionMedicineReceptor Tyrosine KinasePharmacologyCell Biology	2017	531
Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates Matthew P. Patricelli, Anna Katrin Szardenings, Marek Liyanage, Biochemistry Signal Transduction PathwaysBiochemistryProtein FoldingNatural SciencesBioanalysis	2006	427
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 Xianming Deng, Nicolas Dzamko, Alan R. Prescott, Nature Chemical Biology Signal TransductionMedicineReceptor Tyrosine KinaseDisease Kinase Lrrk2Selective Inhibitor	2011	425
In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases Matthew P. Patricelli, Tyzoon Nomanbhoy, Jiangyue Wu, Chemistry & Biology Signal TransductionSignaling PathwayCell RegulationMedicineNatural Sciences	2011	353
Discovery of Potent and Selective Covalent Inhibitors of JNK Tinghu Zhang, Francisco Iñesta-Vaquera, Mario Niepel, Chemistry & Biology Medicinal ChemistryMedicinePharmacologyRational Drug DesignMolecular Docking	2012	351
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain Kay Ahn, Sarah E. Smith, Marya Liimatta, Journal of Pharmacology and Experimental Therapeutics	2011	228
Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity Kyunghye Ahn, Douglas S. Johnson, Laura R. Fitzgerald, Biochemistry Molecular PainPiperidine/piperazine UreaPharmacotherapyBond HydrolaseChemical Biology	2007	214
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith, ACS Medicinal Chemistry Letters Pharmaceutical ScienceMolecular PainPharmacotherapyPharmaceutical ChemistryRat Model	2010	196
C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases Yuying Gosser, Tyzoon Nomanbhoy, Behzad Aghazadeh, Nature N-terminal Inhibitory PeptideProtein FunctionSignal TransductionBiochemistryG Protein-coupled Receptor	1997	170
Lfc and Lsc Oncoproteins Represent Two New Guanine Nucleotide Exchange Factors for the Rho GTP-binding Protein Judith A. Glaven, Ian P. Whitehead, Tyzoon Nomanbhoy, Journal of Biological Chemistry	1996	130

Page 1